Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/1999
11/23/1999US5990280 Factor which is heat resistant but sensitive to acidic and alkaline conditions, does not bind heparin, induced by wild type p53 expression, is not thrombospondin, molecular weight of about 100 kilodaltons; diagnosis, anticarcinogenic agents
11/23/1999US5990279 Transport protein for gene therapy using adeno-associated virus vector
11/23/1999US5990277 Semipeptoid farnesyl protein transferase inhibitors and analogs thereof
11/23/1999US5990276 Synthetic inhibitors of hepatitis C virus NS3 protease
11/23/1999US5990274 Cyclosporine derivatives and uses thereof
11/23/1999US5990273 Synthesis of cyclic peptides
11/23/1999US5990166 Compounds and compositions for delivering active agents
11/23/1999US5990153 Ultrasonicated α-lipoic acid solutions for attenuating microvascular injury
11/23/1999US5990103 Treating psoriasis by topical adminstration of pentoxifylline and diltiazem to a patient; a combination of a compound having a phosphodiesterase-inhibiting action, and a compound which reduces the intracellular calcium content
11/23/1999US5990093 Treating hepatitis b virus (hbv) infections by administering a 5'-phospholipid prodrug of beta-l-2',3'-dideoxyadenosine 5'-monophosphate of given structure optionally with other anti-hbv agents, such as carbovir or 3tc
11/23/1999US5990092 GATA-6 transcription factor: compositions and methods
11/23/1999US5990090 A double-stranded dna nf-kappab inhibitor of given nucleotide sequence is effective for the treatment of immune and inflammatory diseases, cancer, and viral infections
11/23/1999US5990086 Therapeutic uses of BPI protein products for human meningococcemia
11/23/1999US5990085 Inhibin-HBc fusion protein
11/23/1999US5990084 Compounds with growth hormone releasing properties
11/23/1999US5990083 Composition for reducing cu/zn superoxide dismutase-1 enzyme degradation by inhibiting multicatalytic protease; treating muscle wasting diseases associated with low superoxide dismutase-1 enzyme activity
11/23/1999US5990082 Uses of lipopolysaccharide binding protein
11/23/1999US5990081 Purified with an immobilized compound with 2 or 3 nitrogen atoms strongly attaches the endotoxins, and thereby the apoliproteins (apo a or apo e) to the matrix; elution with a surfactant solution releases apo; cardiovascular disorders
11/23/1999US5990080 Use of protein S-100-b in medicines containing the protein S-100b
11/23/1999US5990079 Agents affecting thrombosis and hemostasis
11/23/1999US5990078 Contacting sample of neural tissue with: estrogen to increase the level of neurotrophin receptors, and a neurotrophin to increase the level of estrogen receptors
11/23/1999US5990077 Glp-2 acts as a trophic agent to promote growth of gastrointestinal tissue, particularly increased growth of the small intestine and pancreatic islet; pharmaceutical compositions; treating diabetes
11/23/1999US5989909 Nucleotide and amino acid sequences; for diagnosis and treatment of related diseases; antisense agents
11/23/1999US5989908 Nucleic acid encoding ribozyme used for suppression of c-fos oncogene expression in mammalian cells exhibiting multidrug resistant phenotype; increase cell sensitivity to anticarcinogenic/antitumor agents
11/23/1999US5989907 Methods and compositions for calcium binding proteolipid encoding nucleic acids
11/23/1999US5989905 HCV NS3 protein fragments having helicase activity and improved solubility
11/23/1999US5989904 Rna oligonucleotide which interacts specifically with a cellular protein to prevent binding of protein to internal ribosome entry site; viricides for poliovirus, rhinoviruses, hepatitis viruses, coxsackie viruses and others
11/23/1999US5989890 Compositions and methods for PACE 4 and 4.1 gene and polypeptides in cells
11/23/1999US5989886 Method for the inhibition and prevention of viral replication using fusions of a virus protein and a destructive enzyme
11/23/1999US5989884 Polypeptides of the histidyl transfer rna synthetase family; for screening of antibiotics, bactericides, and bacteristats for treatment and prevention of clamydial infections; diagnosis
11/23/1999US5989866 FGF homologs
11/23/1999US5989864 DNA encoding spo-rel polypeptides
11/23/1999US5989863 Human ankyrin family protein
11/23/1999US5989861 Human ion transport-like protein
11/23/1999US5989859 Antiinflammatory and antiproliferative agents; preventing apoptosis; genetic engineering and expression
11/23/1999US5989858 Dead-type ATP-dependent RNA helicase (DbpB) from Staphylococcus aureus
11/23/1999US5989856 Pharmaceutical composition having an endoproteolytic activity; a process for endoproteolytically processing (precursor) proteins and for the (micro)biological production of proteins
11/23/1999US5989850 Methods of testing cancer cells and anticancer drugs
11/23/1999US5989849 Antisense of oligonucleotides to c-kit proto-oncogene and in vitro methods
11/23/1999US5989843 Measuring labeled phosphate
11/23/1999US5989838 Immunological methods of detecting MN proteins and MN polypeptides
11/23/1999US5989836 Method for measuring the binding sites for macrophage-derived inflammatory mediator (MIP-1α and MIP-1β)
11/23/1999US5989834 Contacting nonneuronal cells transfected with vector; gene expression
11/23/1999US5989833 Methods for detection of molecules with affinity for MPL polypeptides
11/23/1999US5989832 Method for screening for non-tetracycline efflux pump inhibitors
11/23/1999US5989828 Binding to matrix; vaccines
11/23/1999US5989825 Excitatory amino acid transporter gene and uses
11/23/1999US5989822 Diagnosis and treatment of cancer, neurodegenerative and autoimmune diseases; gene expression
11/23/1999US5989810 Interleukin-2 enhancer fused to cassette; adenovirus promoter; nuclear extract; nf-at-dependent inhibitors
11/23/1999US5989807 Polymerase chain reactions
11/23/1999US5989804 E6 binding proteins
11/23/1999US5989803 Method for treating a subject suffering from a condition associated with an extracellular zinc sphingomyelinase
11/23/1999US5989593 Heating in the presence of a stabilizing agent of an organic acid, a saccharide and/or sodium chloride, contacting with a metal chelate resin
11/23/1999US5989584 CCK antibodies used to improve feed efficiency
11/23/1999US5989565 Elution and identification of T cell epitopes from viable cells
11/23/1999US5989564 Pertussis toxoid made by reacting pertussis toxin with the nitrating agent TNM
11/23/1999US5989563 Viral agent associated with mystery swine disease
11/23/1999US5989554 High level expression and facile purification of proteins, peptides and conjugates for immunization, purification and detection applications
11/23/1999US5989551 Materials and methods for detection and treatment of insulin-dependent diabetes
11/23/1999US5989547 Leptospiral outer membrane proteins
11/23/1999US5989546 Interleukin-2 stimulated T lymphocyte cell death for the treatment of allergic responses
11/23/1999US5989545 Clostridial toxin derivatives able to modify peripheral sensory afferent functions
11/23/1999US5989544 Injesting alpha-galactosidase to hydrolyze galactosides
11/23/1999US5989540 Modified adeno-associated virus vector capable of expression from a novel promoter
11/23/1999US5989539 Compounds and compositions for delivering active agents
11/23/1999US5989538 Mpl ligand analogs
11/23/1999US5989537 Methods for stimulating granulocyte/macrophage lineage using thrombopoietin
11/23/1999US5989521 Method for augmenting a decreased level of reduced glutathione in the lung
11/23/1999US5989463 Methods for fabricating polymer-based controlled release devices
11/23/1999CA2167559C Process for drying hydrophobic amino acids with improved process for increased bulk density
11/23/1999CA2103680C Improved blood substitute
11/23/1999CA2022165C Albumin purification
11/23/1999CA1340829C Cloned dna for synthesizing unique glucocerebrosidase
11/23/1999CA1340825C Hyaluronic acid fraction for use as a drug delivery system for medicaments
11/22/1999CA2238656A1 Mammalian staufen and use thereof
11/22/1999CA2238217A1 4e-bp3, a new member of the eukaryotic initiation factor 4e-binding protein family and use thereof
11/21/1999CA2270687A1 Use of a peptide compound in the treatment of systemic lupus erythematosus
11/19/1999CA2237915A1 Osteoporosis treatment
11/18/1999WO1999059037A1 Methods of determining protein activity levels using gene expression profiles
11/18/1999WO1999058699A2 Transgenic plant-derived human blood coagulation factors
11/18/1999WO1999058693A1 Complex formed by a peptide and a major histocompatibility complex at the surface of phages
11/18/1999WO1999058692A2 Human apoptosis associated proteins
11/18/1999WO1999058691A2 Recombinant (alpha)-l-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof
11/18/1999WO1999058685A2 Basb028 polypeptides and polynucleotides encoding therefor from moraxella catarrhalis
11/18/1999WO1999058680A2 Method for diagnosis and treatment of haemophilia a patients with an inhibitor
11/18/1999WO1999058679A1 Antibodies to cd23, derivatives thereof, and their therapeutic uses
11/18/1999WO1999058678A2 Antibodies to dendritic cells and human dendritic cell populations and uses thereof
11/18/1999WO1999058676A2 Semaphorin polypeptides
11/18/1999WO1999058674A2 Method of inhibiting osteoclast activity
11/18/1999WO1999058673A1 Geminin genes and proteins
11/18/1999WO1999058672A1 Human promonocyte associated protein: prmnc
11/18/1999WO1999058671A2 Human and nematode homologues of the yeast longevity assurance gene lag1
11/18/1999WO1999058670A1 Ags proteins and nucleic acid molecules and uses therefor
11/18/1999WO1999058668A1 NOVEL POLYPEPTIDES, cDNAS ENCODING THE SAME AND UTILIZATION THEREOF
11/18/1999WO1999058660A1 97 human secreted proteins
11/18/1999WO1999058658A2 Expression vectors for stimulating an immune response and methods of using the same
11/18/1999WO1999058650A1 Lytic enzymes useful for treating fungal infections
11/18/1999WO1999058647A2 Human deadenylating nuclease, its production and its use
11/18/1999WO1999058645A1 New apoptotic bodies, monocyte derived cells containing the same, a process for their preparation and their uses as vaccines
11/18/1999WO1999058642A2 Secreted proteins and polynucleotides encoding them
1 ... 2452 2453 2454 2455 2456 2457 2458 2459 2460 2461 2462 2463 2464 2465 2466 2467 2468 2469 2470 2471 2472 ... 3163